Paid Clinical Trials for Lung Cancer

Showing 1 – 20 of 82 results

UG3 Pilot Clinical Trial

by CTG

in Lung Cancer

Other

Utah

Deadline:

02/27/2026

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

by CTG

in Brain Metastases, Brain Metastases, Adult, Lung Cancer, Small-cell Lung Cancer, Lung Cancer Metastatic

Other

New Jersey

Deadline:

06/10/2026

Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

by CTG

in Lung Cancer

Other

New Jersey

Deadline:

05/01/2026

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

by CTG

in Lung Cancer, Extensive-stage Small-cell Lung Cancer, Small-cell Lung Cancer

Other

Illinois

Deadline:

10/01/2027

Detection of Genetic Markers of Lung Cancer

by CTG

in Lung Cancer

Other

Pennsylvania

Deadline:

12/01/2050

Increasing Equity in Lung Cancer Screening

by CTG

in Lung Cancer

Other

Indiana

Deadline:

02/01/2027

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

by CTG

in Breast Cancer, Non Small Cell Lung Cancer, Lung Cancer, Esophageal Cancer, Small Cell Lung Cancer

Other

California

Deadline:

03/21/2028

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

by CTG

in Lung Cancer

Other

California

Deadline:

05/30/2026

Virtual Agent Feasibility in Oncology Patients (NTT Data)

by CTG

in Lung Cancer

Other

North Carolina

Deadline:

08/01/2026

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

by CTG

in Lung Cancer, EGFR Gene Mutation

Other

Massachusetts

Deadline:

09/01/2030

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

by CTG

in Lung Cancer, EGFR Gene Mutation

Other

Massachusetts

Deadline:

09/01/2030

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

by CTG

in Lung Cancer, EGFR Gene Mutation

Other

Massachusetts

Deadline:

09/01/2030

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

by CTG

in Lung Cancer

Other

California

Deadline:

09/04/2026

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

by CTG

in Lung Cancer

Other

Tennessee

Deadline:

05/31/2031

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

by CTG

in Non Small Cell Lung Cancer, Lung Cancer, Metastatic Non Small Cell Lung Cancer

Other

New Jersey

Deadline:

03/03/2028

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

by CTG

in Lung Cancer, Cancer of the Lung

Other

Missouri

Deadline:

05/31/2027

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

by CTG

in Breast Cancer, Pancreatic Cancer, Lung Cancer, Colorectal Cancer (CRC)

Other

California

Deadline:

09/30/2027

To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations

by CTG

in Lung Cancer

Other

California

Deadline:

07/07/2027

Evaluation of Improved Onboard Patient Imaging

by CTG

in Breast Cancer, Lung Cancer, Head and Neck Cancer, Pelvic Cancer, Upper Gastrointestinal Cancer

Other

Maryland

Deadline:

12/01/2026

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

by CTG

in Lung Cancer, Lung Transplant, Bilateral Cancer

Other

Illinois

Deadline:

11/01/2032

Load more All clinical trials loaded.

UG3 Pilot Clinical Trial

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Detection of Genetic Markers of Lung Cancer

Increasing Equity in Lung Cancer Screening

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

Virtual Agent Feasibility in Oncology Patients (NTT Data)

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations

Evaluation of Improved Onboard Patient Imaging

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Lung Cancer

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps